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Abstract: Elevated inflammation in pregnancy has been associated with multiple adverse pregnancy
outcomes and potentially an increased susceptibility to future chronic disease. How maternal dietary
patterns influence systemic inflammation during pregnancy requires further investigation. The
purpose of this review was to comprehensively evaluate studies that assessed dietary patterns and
inflammatory markers during pregnancy. This review was guided by the Preferred Reporting Items
for Systematic Review and Meta-Analyses. Included studies were sourced from EMBASE, PubMed,
Web of Science, and Scopus and evaluated using The Quality Assessment Tool for Quantitative
Studies. Inclusion criteria consisted of human studies published in English between January 2007
and May 2020 that addressed associations between dietary patterns and inflammatory markers
during pregnancy. Studies focused on a single nutrient, supplementation, or combined interventions
were excluded. A total of 17 studies were included. Despite some inconsistent findings, maternal
diets characterized by a higher intake of animal protein and cholesterol and/or a lower intake of
fiber were shown to be associated with certain pro-inflammatory markers (C-reactive protein (CRP),
interleukin-6 (IL-6), tumor necrosis factor-α (TNF- α), IL-8, serum amyloid A (SAA), and glycoprotein acetylation (GlycA)). Future studies that explore a broader range of inflammatory markers in
the pregnant population, reduce measurement errors, and ensure adequate statistical adjustment
are warranted.
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1. Introduction
An amplified inflammatory response during pregnancy has been linked to multiple pregnancy complications [1], such as preeclampsia [2], preterm delivery [3], depressive symptoms [4], and recurrent abortion [5]. Maternal inflammation also contributes to programming of fetal metabolic profiles and immune system through epigenetic
modifications [6,7]. Systemic inflammation normally occurs during pregnancy [8]. Proinflammatory markers, such as interleukin-6 (IL-6), tumor necrosis factor-α (TNF- α) [9,10],
and C-reactive protein (CRP) [11], increase significantly over the course of pregnancy.
The immune response is particularly increased at the times of implantation and parturition [12–14] or during periods of excess maternal psychosocial stress [9]. High levels of IL-6
and TNF-α have been positively associated with gestational diabetes mellitus (GDM) [15].
Elevated CRP and IL-8 have been associated with an increased risk of preeclampsia [16].
The activation of inflammasomes, which induce interleukin 1β (IL-1β) secretion, has been
linked to maternal obesity, preterm birth, and preeclampsia [13]. Pro-inflammatory cytokines (IL-6, TNF-α, IL-8, IL-1β) have been found to remain elevated or increase in the
first month after childbirth [10]. Women with a history of preeclampsia and persistent
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inflammation during postpartum have an increased risk of cardiometabolic disease and
neurodegenerative disorders later in life [17].
The immune response is activated as the body attempts to restore homeostasis following an irritant stimulus [18]. If the response is amplified, increased oxidative stress and
vasoconstriction may result in adverse pregnancy outcomes [1]. Activated transcription
factors (e.g., nuclear factor kappa-B (NF-κB)) and increased inflammatory cytokines, in
turn, amplify inflammatory response and contribute to the development and progression
of disease processes [18,19]. In the non-pregnant population, chronic inflammation has
been shown to contribute to the development of autoimmune disorders [20], endothelial
dysfunction [21], cardiometabolic disorders [20,22,23], and increased risk of cardiovascular
morbidity and mortality [24]. Pharmacotherapy targeted at IL-1β [25] and TNF-α [24] has
been shown to successfully improve cardiovascular and endothelial function, suggesting
that controlling the inflammatory response is a potential target for research.
Evidence from global studies has indicated that diet has a crucial role in the prevention
of chronic disease and mortality [6,26]. Multiple nutrients and bioactive substances, such
as vitamin E, affect the processes of intracellular signaling and the expression of genes
involved in inflammation, with consequent reduction of pro-inflammatory cytokine synthesis [19]. For example, plant phenolic compounds enhance immune function [27] and reduce
certain enzymes involved in the generation of reactive oxygen species [28]. Polyphenol
antioxidants can modulate immune homeostasis and intracellular signaling by inactivating the NF-κB pathway, modulate mitogen-activated protein kinase (MAPK) [27,29], and
suppress toll-like receptor (TLR) [28]. Omega-3 polyunsaturated fatty acid attenuates the
activation of TLR4, thereby reducing the production of pro-inflammatory mediators [30].
Conversely, increased dietary exposure to saturated fatty acids and free fatty acids trigger
the activation of the c-Jun N-terminal kinase (JNK) and IκB kinase-β (IKKβ) signaling
pathways [31,32]. A high-fat diet has been linked to increased intestinal permeability (leaky
gut), resulting in an altered gut microbiome [33] and increased lipopolysaccharide (LPS)
(bacterial endotoxins) [34], which activate TLR4 [30]. A complex network of signaling pathways is involved in the interaction of dietary and microbial metabolites and the production
of inflammatory mediators [18,19].
An increased interest in synergistic interactions among individual nutrients and, ultimately, dietary patterns has emerged [35]. Dietary patterns refer to foods and beverages
that are habitually consumed with respect to their amounts, proportions, variety, combinations, and/or frequency [36]. In the non-pregnant population, high intake of fruits
and vegetables, such as in the Nordic diet and Mediterranean diet, have been shown to
reduce inflammation [37–40] and promote endothelial function [38] and cardiovascular
health [37,41]. On the other hand, a high intake of saturated fats, added sugars, and
simple carbohydrates have been linked to increased inflammatory markers (CRP/high
sensitivity (hs)-CRP, IL-6) [42,43] and risk of hypertension [44] and cardiovascular disease [37,45]. Adherence to a Mediterranean diet may modulate low-grade inflammation
in pregnancy [46]. A randomized clinical trial (RCT) using a combined lifestyle approach
demonstrated the positive effects of carbohydrates on hs-CRP concentrations in late pregnancy [47]. Inflammation-targeted nutrition therapy may provide potential prophylaxis,
but little is known about which dietary pattern influences systemic inflammation and
which inflammatory markers are altered by diet during pregnancy. Therefore, the aim
of this review is to synthesize the current empirical evidence concerning the relationship
between dietary patterns and the inflammatory response and identify the inflammatory
markers associated with dietary patterns during pregnancy.
2. Materials and Methods
This review was guided by the Preferred Reporting Items for Systematic Review
and Meta-Analyses (PRISMA). Articles were sourced from 4 databases, namely, EMBASE,
PubMed, Web of Science, and Scopus. The literature search was undertaken in September
2018 and updated in May 2020. The search strategy was adapted for each database using
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keywords as follows: inflammation OR “inflammatory markers” AND pregnancy OR
“pregnant women” AND diet OR “dietary patterns.” No restrictions or filters were applied
to the search in the title, abstract, or keywords. Two reviewers (K.Y. and A.K.) independently performed the screening of titles and abstracts, followed by full-text assessment
as needed.
The screening process involved the following inclusion criteria: (1) pregnant women
as the target population, (2) maternal dietary patterns as the predictor or independent
variable, (3) peripheral blood markers of inflammation as the outcome or dependent variable, (4) emphasis on dietary patterns rather than single nutrients, (5) publication in a
peer-reviewed journal between 2007 and 2020, (6) intervention or observational studies,
(7) publication in English, and (8) human studies with full-text only. For multiple publications based on the same study, only the one with the largest sample size was included.
Studies on supplementation or dietary exposure combined with other lifestyle interventions were excluded. The reference lists of included articles were carefully reviewed to
identify any additional eligible studies. The screening process was conducted using Endnote and Abstrackr software. Data extraction included several key components (i.e., author,
country, study design, participant characteristics, sample size, dietary pattern(s), reference
period, dietary assessment tool, and the main findings related to the levels of inflammatory
markers) that were verified by a second reviewer. All discrepancies were discussed, and a
consensus was reached.
The quality of included studies was independently assessed by 2 reviewers (K.Y. and
B.L. or A.K.) using the “Quality Assessment Tool for Quantitative Studies” developed by
the Effective Public Health Practice Project (EPHPP) [48]. This appraisal tool has a strong
rating in methodology and has been widely used in public health research [48]. Studies
were evaluated on 8 key components, namely, selection bias, study design, confounders
accounted for, blinding, data collection methods, withdrawals and dropouts, intervention
integrity, and analysis. If any of the essential information for the EPHPP quality assessment
was absent, cited references were reviewed in detail. A global ranking of strong, moderate,
or weak was determined on the basis of the first 6 criteria in accordance with the guideline
recommendations [48]. Any discrepancies between the two reviewers’ data extraction
and global ratings, the included articles, and its relevant reference were reassessed and
discussed, and a consensus was reached. A third person was approached for the resolution
of any unresolved discrepancies.
3. Results
A total of 2639 relevant articles from four databases were extracted, including two
articles identified through a review of article reference lists. Of those, 983 duplicates were
removed, and the titles and abstracts of the remaining 1656 studies were screened for
their eligibility on the basis of inclusion and exclusion criteria. Following the screening,
an additional 1626 articles that did not meet the inclusion criteria were excluded. Of the
remaining 30 studies, 13 were determined ineligible on the basis of a full-text evaluation.
A total of 17 articles were included in the present review. The detailed process of article
selection based on the PRISMA guidelines is presented in Figure 1.
3.1. Study Characteristics
Characteristics of the included studies are outlined in Table 1. Included studies
were conducted in 10 countries from 5 continents, namely, Europe, Australia, Asia, and
South and North America. Six studies were from the United States [3,49–53], two were
from Iran [54,55], and one each was from China [56], Lebanon [57], the United Kingdom [58], Norway [59], Denmark [60], Australia [61], Finland [62], Ireland [63], and
Brazil [11]. Among the included studies, four studies were randomized controlled trials
[54,58,59,61]. Sample sizes ranged from 32 [54] to 290 [61], and intervention duration ranged
from four weeks [54] to five months [58]. Seven studies were prospective cohort designs
[3,11,49–52,56] with the sample sizes ranging between 116 [11] to 1808 [52]. Five studies
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were cross-sectional [53,57,60,62,63], with the sample sizes ranging between 100 [62] to
621 [63], and one study was a case-control study with 135 participants [55].

Figure 1. Literature was searched in September 2018 and updated in May 2020. The included studies were published from
2007 to
to May
May 2020.
2020.

Study samples were diverse and representative of a variety of pregnant populations.
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conditions as part of the enrollment criteria [49,53]. Nine studies described the education
distribution of their study sample, indicating the majority of participants had achieved a
high school degree or higher [11,49–53,55,61,62].
3.2. Dietary Patterns
The observational studies included a priori defined dietary patterns, such as the
Mediterranean diet [57], low/high glycemic index (GI) diet, low/high glycemic load
(GL) diet [3,11], and pro-/anti-inflammatory diets using the Dietary Inflammatory Index
(DII) [50–53,55,56] or Energy-Adjusted Dietary Inflammatory Index (E-DII) [49]. Other
dietary patterns were a posteriori derived through a statistical approach with an emphasis
on the proportions of macronutrients [40,49,51], fiber [49,51], or cholesterol [51].
Dietary interventions following a priori-defined dietary patterns included the addition
of salmon biweekly [58], a low-GI diet [61], an anti-atherogenic diet [59], and the Dietary
Approaches to Stop Hypertension (DASH) diet [54]. Common characteristics of these
diets included high amounts of fresh plant-based foods (e.g., fruits and vegetables and
whole grains) and low intake of processed meats and animal fats [64,65]. These patterns
are largely in accordance with the Global Action Plan for the Prevention and Control of
Noncommunicable Disease [65].
3.3. Dietary Assessment
A variety of dietary assessment tools, including food frequency questionnaires (FFQ),
24-hour dietary recalls, and three-day food diaries/records, were utilized to measure
dietary intake. FFQs were used in seven studies [11,49,52,55,57,58,60]. The number of
items on the FFQs ranged from 100 [58] to 168 [55]. The reference periods of the FFQs
varied from the previous 3 months [52,60,66], 3 to 6 months [49], or 12 months [67,68].
The questionnaires were specifically developed for assessing the Mediterranean diet [57],
the Middle Eastern diet [69], the Brazilian diet [11], marine n-3 fatty acids intake [60],
or the nutrient intake in pregnant Caucasian women [58]. Two were adapted from the
Willett questionnaire [52,55]. One was developed by the University of Texas MD Anderson
Cancer Center [49]. Six studies used 24-hour dietary recalls. Of these, two utilized a single
recall [53,57], and four used repeated recalls collected consecutively for three days [56] or
non-consecutively at two time-points [3], at three time-points [50,61], or every month during
pregnancy [51]. Three-day food diaries/records were used in three studies [54,61,62].
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Table 1. Characteristics of the studies examining the relationship between diet and inflammatory biomarkers.

Study Design

Reference -Country/Sample Size

de Oliveira et al.,
2015
-Brazil [11]

Lindsay et al.,
2018
-USA [50]

115

202

Maternal Age
(Years Old)

20–40

>18

Health Status and
Gestational Age
at Enrollment

Healthy;
5–13 weeks of
gestation

Healthy during
the first or early
second trimester

Dietary Exposure
/Control

Dietary
Assessment Tool
(FFQ Reference
Period)
Time of Dietary
Data Collection

Glycemic load
(GL) ≥ median
/Glycemic load
(GL) < median

A 73-item FFQ (a
12-month
reference period)
[67] collected at
weeks 20–26 of
gestation.

Anti-/proinflammatory diet

Interviewer
administered 24-h
dietary recalls
collected at mean
week 12.9 ± 1.7,
20.5 ± 1.4, and
30.4 ± 1.4 of
gestation.

Anti-/proinflammatory diet

FFQ (a 6-month
reference period)
during
peri-conceptional
stage) at 3-time
points: enrollment
(median ~ 12
weeks), the second
trimester (diet in
the first trimester),
between 36 weeks
of gestation to
delivery (diet in
the last 2
trimesters), and at
delivery as
needed.

Prospective cohort
study

McCullough et al.,
2017
-USA [49]

1057

≥18

Ethnically diverse;
<12 weeks of
gestation

Time of Blood
Collection

(Fasting) blood
sample at 3
timepoints (weeks
5–13, 20–26, 30–36
of gestation)

Day 6 of each
assessment period
at 10–12 weeks,
20–22 weeks,
30–32 weeks of
gestation

The blood sample
was taken before
12 weeks of
gestation

Examined
Inflammatory
Markers

Main Findings

CRP

Dietary glycemic
load was
negatively
associated with
CRP
concentrations (β
= –0.203; 95% CI,
–0.380 to –0.026, p
= 0.025).

TNF-α

The DII scores
ranged from –4.3
to 3.7 using 32
food parameters.
DII was positively
associated with
TNF-α (β = 0.093,
95% CI:
0.023–0.163, p =
0.010).

INFγ, IL-12,
IL-17A, IL-1β,
IL-4, IL-6, and
TNF-α

The E-DII scores
ranged from –5.00
to 4.96 using 27
food parameters.
The correlation
between maternal
E-DII and
circulating
cytokines was not
significant (p >
0.05).
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Table 1. Cont.

Study Design

Reference -Country/Sample Size

Moore et al., 2018
-USA [51]

511

Maternal Age
(Years Old)

≥16
(28 ± 6)

Health Status and
Gestational Age
at Enrollment

Healthy singleton
pregnancy;
<24 weeks of
gestation

Dietary Exposure
/Control

Anti-/proinflammatory diet

Dietary
Assessment Tool
(FFQ Reference
Period)
Time of Dietary
Data Collection

One ASA24 per
month. At least
one per
participant. Visits
in early pregnancy
(median 17 weeks
of gestation),
mid-pregnancy
(median 27 weeks
of gestation), and
at delivery
(median 1 day
after delivery)

Time of Blood
Collection

Blood sample at 27
weeks of gestation

Examined
Inflammatory
Markers

Main Findings

IL-6, hs-CRP

The DII scores
ranged from –4.4
to 4.0 using 28
food parameters.
For each 1 unit
increase in the DII,
a 0.12 mg/L
increase in IL-6
levels was
detected at 27
weeks of gestation
(95% CI, 0.01–0.24;
p = 0.03). No
association was
observed with
hs-CRP (p = 0.27).

hs-CRP

Higher intakes of
protein (p = 0.002)
and cholesterol (p
= 0.0016) with a
lower intake of
carbohydrate (p =
0.023), as well as a
higher dietary
glycemic index (p
= 0.013) were
associated with
increased hs-CRP.
only among lean
gravidae (BMI <25
kg/m2 ).

Prospective cohort
study

Scholl et al., 2011
-US [3]

520

Teenage and 19–32
[70]

Healthy;
<20 weeks of
gestation

The proportion of
multiple dietary
components

Two 24 dietary
recalls at entry
into prenatal care
and at weeks
20–28 of gestation

(GCT) at entry
into prenatal care
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Table 1. Cont.

Study Design

Reference -Country/Sample Size

Sen et al., 2016
-USA [52]

1808

Maternal Age
(Years Old)

32.2 ± 5.0

Health Status and
Gestational Age
at Enrollment

Non-diabetic at
median 9.9 weeks
of gestation

Dietary Exposure
/Control

Dietary
Assessment Tool
(FFQ Reference
Period)
Time of Dietary
Data Collection

Anti-/proinflammatory diet

A 146-item FFQ
and 33 items for a
supplement intake
assessment
[71] (last
menstrual period
for the first
trimester or
previous three
months during the
second trimester).

Time of Blood
Collection

(GCT) at weeks
22–31 of gestation

Examined
Inflammatory
Markers

Main Findings

CRP

The DII scores
ranged from –5.4
to 3.7 using 28
food parameters.
Higher DII was
associated with
higher plasma
CRP in the second
trimester (β = 0.08,
95% CI: 0.02–0.14).

hs-CRP

The odds of
having high levels
of hs-CRP in
pro-inflammatory
diet group were
1.89 times greater
than the odds of
having high levels
of hs-CRP in the
anti-inflammatory
diet group (95%
CI: 1.05, 3.42, p =
0.043).

hs-CRP

Difference in
mean change of
serum hs-CRP
between DASH
and control diet
was not significant
(p > 0.05).

Prospective cohort
study

Yang et al., 2020
-China [56]

Randomized
controlled clinical
trial

Asemi et al., 2013
-Iran [54]

307

32

28.5 ± 3.4

18–40

Healthy with
normal BMI;
16–20 weeks of
gestation

GDM;
24–28 weeks of
gestation

Anti-/proinflammatory diet

Dietary recall for
three consecutive
days since the
date of enrollment
around 16–20
weeks of
pregnancy.

(Fasting) after
dietary
assessment in the
second trimester

DASH
/based on
recommended
acceptable dietary
intake for GDM

Three-day food
diaries throughout
4-week
intervention
period (24–28
weeks of
gestation).

(Fasting) blood
sample at 24–28
weeks of gestation
and after 4-week
intervention
period
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Table 1. Cont.

Study Design

Reference -Country/Sample Size

Garcia-Rodriguez
et al., 2012
-United Kingdom
[58]

Khoury et al., 2007
-Norway [59]

123

290

Maternal Age
(Years Old)

18–40

21–38

Health Status and
Gestational Age
at Enrollment

Healthy;
<19 weeks of
gestation

Healthy,
non-smoking;
17–20 weeks of
gestation

Dietary Exposure
/Control

Dietary
Assessment Tool
(FFQ Reference
Period)
Time of Dietary
Data Collection

Time of Blood
Collection

Examined
Inflammatory
Markers

Main Findings

Twice a week (150
g/portion) of
salmon
/habitual diet low
in oily fish

A 100-item FFQ (a
12-week reference
period) [66]
collected at weeks
19/20 and 34 of
gestation; a diary
between week 20
of gestation to
delivery.

(Fasting) blood
sample at week 20,
weeks 32–34 of
gestation and at
week 38 of
gestation

IL-8, IL-6, TNF-α,
HGF, NGF, MCP-1
sCAMs (E-selectin,
ICAM-1,
VCAM-1)

Inflammatory and
vascular
homeostasis
biomarkers were not
affected by the
intake of farmed
salmon (p > 0.05).

Anti-atherogenic
diet (low in
saturated fat and
cholesterol)
/usual diet

Weighed
recordings of
intake from
baseline weeks
17–20 to week 36
of gestation.

hs-CRP, sCAMs
(sVCAM-1,
sICAM-1 and
E-selectin)

None of the
biomarkers were
influenced by the
intervention (low
saturated fat/low
cholesterol diet)
compared to the
control group (usual
diet) (p > 0.05).

Low glycemic
index (LGI)
/high-fiber,
moderate GI diet

Two 3-day food
records collected
at weeks 14–20
and 36 of gestation
and three 24-hour
dietary recalls as
dietary
compliance
measure collected
at weeks 18–24,
22–28, 26–32 of
gestation; five
dietary
consultations from
weeks 14–20
through 34–36 of
gestation.

CRP

Difference in CRP
between the low
glycemic diet group
and high fiber group
was not significant
at the end of the
intervention period
(p > 0.05).

Randomized
controlled clinical
trial

Markovic et al.,
2016 (GI baby3)
-Australia [61]

139

>18

At high risk of
GDM;
12–20 weeks of
gestation

Blood sample at
weeks 17–20, week
24, week 30, and
week 36 of
gestation

(Fasting) at mean
week 17.4 ± 2 and
at week 36 of
gestation
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Table 1. Cont.

Study Design

Reference -Country/Sample Size

Hrolfsdottir ˆ et al.,
2016
-Denmark [60]

671

Maternal Age
(Years Old)

29 ± 4

Health Status and
Gestational Age
at Enrollment

Healthy;
283 ± 11 days of
gestation

Dietary Exposure
/Control

Protein intake and
distribution
between animal
and plant sources

Dietary
Assessment Tool
(FFQ Reference
Period)
Time of Dietary
Data Collection

A 3-item
self-administered
FFQ combined
with an interview
(a 3-month
reference period)
[72] collected at
week 30 of
gestation.

Time of Blood
Collection

Blood sample at
week 30 of
gestation

Examined
Inflammatory
Markers

Main Findings

hs-CRP, SAA, IL-6,
IL-8, IL-1β, TNF-α

Women in the
highest compared
to the lowest
quintile of animal
protein intake had
25% (95% CI: 2–53,
p = 0.004) higher
hsCRP
concentrations. A
similar pattern
was observed for
SAA (23%, 95% CI:
4–47, p = 0.003).
Fiber intake was
inversely
associated with
IL-8 (–24%, 95%
CI: –37 to –9, p =
0.028).

CRP

Higher
Mediterranean
diet score was
associated with
lower CRP levels.
MFP (OR: 0.90,
95% CI: 0.82–0.99,
p = 0.03); MDS
(OR: 0.88, 95% CI:
0.78–0.99, p = 0.04);
Med Diet Score
(OR: 0.88, 95% CI:
0.80–0.98, p = 0.02);
SMDQ (OR: 0.91,
95%CI: 0.83–0.99,
p = 0.04).

Cross-sectional

Papazian et al.,
2019
-Lebanon [57]

100

18–40

Healthy singleton
pregnancy;
14–27 weeks of
gestation

Mediterranean
diet adherence

A 157-item FFQ
(12 categories of
food groups;
unspecified
reference period)
and one 24-hour
recall collected
between 14 and 27
weeks of
gestation.

(Fasting) blood
collection in the
second trimester
of pregnancy
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Table 1. Cont.

Study Design

Reference -Country/Sample Size

Roytio et al. #,
2017
-Finland [62]

100

Maternal Age
(Years Old)

30.1 ± 4.7

Health Status and
Gestational Age
at Enrollment

Overweight and
obese;
≤17 weeks of
gestation

Dietary Exposure
/Control

Three groups: low
fiber/moderate fat
; high
fiber/moderate
fat;
low fiber/high fat

Dietary
Assessment Tool
(FFQ Reference
Period)
Time of Dietary
Data Collection

One 3-day food
diary per
participant within
the week before
the study visit.

Time of Blood
Collection

(Fasting) at mean
week 13.3 ± 2.4 of
gestation

Examined
Inflammatory
Markers

Main Findings

hs-CRP, GlycA

Recommended
dietary intake (DRI)
of total fat and fiber
was associated with
lower levels of
GlycA. Correlations
between fiber total
and GlycA were
significant (r = 0.316,
p = 0.01). No
association was
found between
microbiota or
intakes of nutrients
and hs-CRP (p >
0.05).

CRP

The DII scores
ranged from –4.98 to
4.14 using 27 food
parameters. DII was
not associated with
CRP (p > 0.05).
Women who were
obese before
pregnancy had
increased odds for
being in the highest
tertile of the DII and
highest tertile of
CRP concentration
compared to women
with normal weight.

Cross-sectional

Shin et al., 2017
-USA [53]

561

20–44
[73]

NHANES samples
at mean 5.35 ± 0.4
months of
gestation

Anti-/proinflammatory diet

Single 24-hour
dietary recall in
the second
trimester.

Blood sample in
the second
trimester

Nutrients 2021, 13, 834

12 of 23

Table 1. Cont.

Study Design

Cross-sectional

Case-control

Reference -Country/Sample Size

Walsh et al. *, 2014
-Ireland [63]

Vahid et al., 2017
-Iran [55]

621

135

Maternal Age
(Years Old)

≥18

20–45

Health Status and
Gestational Age
at Enrollment

Secondigravid
whose baby had
macrosomia (birth
weight > 4000 g)
[74]

With a history of 3
or more
miscarriages after
week 20 of
gestation

Dietary Exposure
/Control

Low glycemic
index (LGI) advice
/not receiving LGI
advice

Anti-/proinflammatory diet

Dietary
Assessment Tool
(FFQ Reference
Period)
Time of Dietary
Data Collection

A five-point
Likert-type scale
as an adherence
measure at week
34 of gestation.

A 168-item FFQ (a
12-month
reference period
[68]).

Time of Blood
Collection

(Fasting) blood
sample at mean
week 13.8 ± 2.4
and 28 weeks of
gestation

Unspecified

Examined
Inflammatory
Markers

Main Findings

TNF-α, IL-6

Differences between
those who did and
those who did not
receive low-GI
dietary advice were
not significant with
respect to the
concentrations of
serum TNF-α or IL-6
in early pregnancy
(prior to the
intervention) or at
28 weeks of
gestation (p > 0.05).

IL-6, CRP

The DII scores
ranged from –0.50 to
2.70 using 31 food
parameters. For
every 1 unit increase
in DII, a
corresponding
increase in IL-6 by
0.15 pg/mL was
detected (95% CI:
<0.01–0.28, p = 0.04);
no significant
association was
observed with CRP
(p = 0.22).

Note: ASA24, Automated Self-Administered 24-hour Dietary Recall; BMI, body mass index; DII, Dietary Inflammatory Index; DRI, dietary reference intakes; E-DII, Energy-Adjusted Dietary Inflammatory Index;
FFQ, Food Frequency Questionnaire; GCT, glucose challenge test; GlycA, glycoprotein acetylation; HGF, hepatocyte growth factor (cytokine); sICAM-1, soluble intercellular adhesion molecule-1; IFNγ, interferon
gamma (cytokine); IL-6, interleukin-6; IL-1β, interleukin-1β; MCP-1, monocyte chemotactic protein-1 (chemokines); MDS, Mediterranean Diet Score; MDScale, Mediterranean Diet Scale; MedDietScale, the
Mediterranean Diet Score; MFP, Mediterranean Food Pattern; NGF, nerve growth factor; NHANES, The National Health and Nutrition Examination Survey; SAA, serum amyloid A; sCAMs, soluble cell adhesion
molecules; SMQD, Short Mediterranean Diet Questionnaire; TNF-α, tumor necrosis factor-α; sVCAM-1, soluble vascular adhesion molecule-1. ˆ Cross-sectional analysis of a cohort study. # An exploratory
analysis of an observational study. * Secondary analysis of a randomized controlled trial.
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Eight of the studies included only a single dietary measure to assess maternal dietary
patterns in the first trimester [62], the second trimester [53–56,60], or both the first and
second trimester [11,57]. A total of eight studies included repeated dietary measures during
the first half of pregnancy [3,52], the second half of pregnancy [58,59,61], or throughout
the entire pregnancy [49–51]. Dietary compliance was tracked in the intervention studies
with a self-reported five-point Likert adherence scale [63], a fish consumption diary [58],
multiple 24-hour dietary recalls [61], or a weighted dietary measure on a pre-determined
day every week [59]. Notably, nearly half of the studies [3,50,51,56,57,60,62,63] did not
include an assessment or estimation of dietary supplement intake, which is essential to
estimate total nutrient intake.
3.4. Peripheral Markers of Inflammation
The most frequently exmined inflamatory markers in relation to diet were CRP
[11,52,53,55,57,61]/hs-CRP [3,51,54,56,59,60,62] and cytokines (cell signaling molecules) including TNF-α [49,50,58,63], IL-6 [49,51,55,58,63], and IL-8 [58,60]. Less explored cytokines
were IL-1β, IL-4, IL-17A, IL-12p70, interferon gamma (IFNγ) [49], hepatocyte growth
factor (HGF), and monocyte chemotactic protein-1 (MCP-1)—a subfamily of cytokines [58].
Soluble cell adhesion molecules (sCAMS) included vascular adhesion molecule-1 (sVCAM1), intercellular adhesion molecule-1 (sICAM-1), and E-selectin [58,59]. Other reported
inflammatory markers were glycoprotein acetylation (GlycA; a novel low-grade inflammatory marker) [62], serum amyloid A (SAA; an acute-phase protein) [60], and nerve
growth factor (NGF; neuroinflammatory markers) [58]. Blood specimens were drawn
from pregnant women in a fasted state [11,54,56–58,61–63] or during glucose screening tests [3,52]. A variety of biochemical analysis techniques were used in detecting
and quantifying inflammatory markers, including enzyme-linked immunosorbent assay
(ELISA) [3,54,57,63], nephelometry [53], immunoturbidimetry [11,51,56], and multiplexed
method [49,51,52,58,60].
3.5. Risk of Bias Assessment
The quality assessment of the included studies is displayed in Table 2. Strong ratings
in selection bias were given to studies with participation rates above 80% [3,54]; weak
ratings were given to studies with participation rates less than 60% [61,62]. Only RCTs
were rated as strong in study design. Randomization was performed using a random
number table [58,59,66] or computer software program [54,61,63,74]. For confounders,
strong ratings were given to RCTs with groups balanced at baseline [54,58,59,61], the
cross-sectional analysis of an RCT [63], and eight observational studies [3,11,49–53,60]
that controlled for a number of possible confounding variables (e.g., age, BMI, ethnicity,
education, income, parity, smoking). Moderate ratings were given to two observational
studies that did not control for smoking status [55,56], which is a notable confounding
variable. Two cross-sectional studies that controlled for less than 60% of confounders [57,62]
were identified as weak. A few studies addressed anti-inflammatory medication use [62]
and acute inflammatory conditions [11,50,55,57].
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Intervention
studies

Cross-sectional
studies

Case–control
studies

Confounders

Blinding

Data Collection
Methods

Withdrawals
Dropouts

Prospective
cohort studies

First Author, Year

Study Design

Study Design

Selection Bias

Table 2. Quality of the included studies assessed by the quality assessment tool for quantitative studies.

Global
Rating

de Oliveira et al., 2015 [11]

m

m

s

w

m

s

Moderate

Lindsay et al., 2018 [50]

m

m

s

w

s

m

Moderate

McCullough et al., 2017 [49]

m

m

s

w

s

s

Moderate

Moore et al., 2018 [51]

m

m

s

w

s

m

Moderate

Scholl et al., 2011 [3]

s

m

s

w

s

m

Moderate

Sen et al., 2016 [52]

m

m

s

w

s

s

Moderate

Yang et al., 2020 [56]

m

m

m

w

s

s

Moderate

Asemi et al., 2013 [54]

s

s

s

s

s

s

Strong

Garcia-Rodriguez et al.,
2012 [58]

m

s

s

m

m

s

Strong

Khoury et al., 2007 [59]

m

s

s

m

w

m

Moderate

Markovic et al., 2016 [61]

w

s

s

m

s

s

Moderate

Hrolfsdottir ˆ et al., 2016 [60]

m

m

s

w

m

m

Moderate

Papazian et al., 2019 [57]

m

m

w

w

s

s

Weak

Roytio # et al., 2017 [62]

w

m

w

w

s

s

Weak

Shin et al., 2017 [53]

m

m

s

s

m

m

Strong

Walsh * et al., 2014 [63]

m

m

s

w

s

s

Moderate

Vahid et al., 2017 [55]

m

m

m

w

s

m

Moderate

Notes: Global rating (criteria): strong (no weak rating), moderate (one weak rating), and weak (two or more weak rating) [65].
ˆ Cross-sectional analysis of a cohort study. # An exploratory analysis of an observational study. * Secondary analysis of a randomized controlled trial.

A double-blind design in the RCTs was considered strong [54], and a single-blind
design moderate [58,59,61]. All observational studies, with the exception of the study
using the data from National Health and Nutrition Examination Survey (NHANES) [53],
were rated as weak for blinding. Strong ratings were given to the studies using standard
assessment tools (e.g., Willett FFQ or 24-hour dietary recalls) [3,49–52,55–57,61–63]. Instruments with known validity or reliability are recognized to have good ratings in data
collection methods per the EPHPP dictionary [75]. The study using one single 24-hour
dietary recall for measuring dietary intake [53] was rated as moderate. The method of using
predetermined days for dietary reporting, which is likely to be altered by social disability,
was evaluated as weak [59]. Moderate ratings in withdrawals and dropouts were given to
studies with a case–control design [55], a study completion rate of less than 80% [51,53,60],
a lack of reporting the reasons for withdrawal [59], or only reporting the number of cases
with completed data [3,50]. Overall, the majority of the included studies were classified as
moderate methodological quality [3,11,49–52,55,56,58–61,63]. Two studies were classified
as weak quality [57,62], and three studies were classified as strong quality [53,54,58].
3.6. Dietary Patterns and Inflammatory Markers
Dietary patterns described in the studies were not uniform and therefore were categorized on the basis of how the pattern was defined (a posteriori-derived vs. a priori-defined)
along with the research design. The majority of observational studies (n = 10) indicated
a statistically significant association (p < 0.05) between diet and inflammatory markers
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(CRP/hs-CRP, IL-6, IL-8, TNF-α, SAA, or GlycA). However, diet–inflammation associations
were not found in the intervention studies.
3.6.1. Proportions of Protein, Cholesterol, and/or Fiber
A posteriori-derived approach was used to examine the proportions of macronutrients
among the observational studies. Dietary patterns characterized by higher cholesterol and
protein intake were associated with increased hs-CRP in the first trimester [3]. Protein from
animal sources was associated with higher hs-CRP and SAA in the third trimester [60].
Lower fat (especially saturated fatty acids) and higher fiber intake contributed to greater
diversity and richness of the gut microbiome, which was correlated with lower GlycA but
not hs-CRP in the first trimester [62]. Dietary intake of fiber was found to be inversely
correlated with levels of CRP in the second trimester [57] and IL-8 in the third trimester [60].
3.6.2. Anti-/Pro-Inflammatory Diet
In the observational studies, some inconsistencies were found among the studies of
pro-inflammatory diets quantified by the DII (the higher the pro-inflammatory potential
of diet, the higher the DII). DII was shown to be positively associated with levels of
CRP [52]/hs-CRP [56] during the second trimester when repeated dietary measures were
used. Conversely, a positive association between DII and hs-CRP in the second trimester
was not found using a single 24-hour dietary recall [53]. The associations between DII and
CRP/hs-CRP were not statistically significant in the first [55] or third [51] trimester. Certain
cytokines were positively associated with DII, including IL-6 in the first [55] and second [51]
trimesters and TNF-α across all three trimesters [50]. Notably, the association between
DII and TNF-α was only observed in pregnant women with high levels of stress [50].
Inflammatory diets measured by the E-DII were not associated with circulating cytokines
(TNF-α, IL-6, IL-1b, IL-4, IL-17A, IL-12p70, IFNγ) in early pregnancy [49].
3.6.3. High/low GI/GL Diet
With respect to carbohydrate content and associated glycemic burden, the results were
mixed among the observational and intervention studies. In one cohort study, GI was
positively associated with hs-CRP among healthy women with a BMI less than 25 kg/m2 ;
dietary glycemic load (GL), which addresses both the quality and quantity of carbohydrates,
was not associated with hs-CRP levels in the first trimester [3]. In contrast, a different
cohort study indicated a non-significant association between GI and CRP, but an inverse
association between GL and CRP in healthy women throughout pregnancy [11]. An
intervention of low GI advice had no impact on levels of CRP in women with a high risk of
GDM [61] nor on IL-6 and TNF-α in women at high risk for macrosomia [63] in the second
half pregnancy.
3.6.4. Mediterranean Diet, DASH Diet, Anti-Atherogenic Diet, and Omega-3 Fatty
Acid-Enriched Diet
Findings from an observational study indicated a significant association between
higher adherence to the Mediterranean diet and lower CRP levels in the second trimester [57].
However, an effect of diet on inflammation was not observed in the intervention studies
focusing on an anti-atherogenic diet [59], a DASH diet [54], or omega-3 fatty acid-enriched
diet [58]. Specifically, an intervention using the DASH diet had no significant effects on
levels of hs-CRP in the second trimester [54]. An anti-atherogenic diet had no effect on
levels of hs-CRP and sCAMS [59], and regular salmon intake had no effect on IL-8, IL-6,
TNF- α, HGF, NGF, MCP-1, HGF, or sCAMS in the second half of pregnancy [58].
4. Discussion
This systematic review presents evidence from observational studies and controlled trials of relationships between maternal dietary patterns and inflammatory markers. Dietary
patterns explored in this review included the pro-/anti-inflammatory diet, low GI/GL
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diet, Mediterranean diet, DASH diet, and an anti-atherogenic diet. Additionally, the
macronutrient composition and regular salmon intake, which addressed the proportions
or frequency of dietary components, were examined. Overall, about two-thirds of the
studies with moderate quality in methodology per EPHPP showed associations between
dietary patterns and pro-inflammatory markers; however, the three studies with strong
methodology did not report significant associations, including one observational study [53]
and two intervention studies [54,58].
4.1. Evidence from the Observational Studies
A dietary pattern with high animal protein, high cholesterol, and/or low fiber was
significantly associated with higher levels of CRP [52,57,60]/hs-CRP [3,56] and SAA [60]
during pregnancy. Lower fiber intake was associated with higher IL-8 [60] and reduced
gut microbiota richness, which contributes to higher GlycA [62]. Interestingly, microbiota
composition was not correlated to hs-CRP, suggesting a possible different mechanism
of inflammation [62]. Diets categorized as low-DII [50–52,55,56] were associated with
lower levels of pro-inflammatory markers in pregnancy. Dietary intake with less antiinflammatory food parameters (e.g., fiber, vitamins, β-carotene, and flavones) and more
pro-inflammatory food parameters (e.g., saturated fats, cholesterol) were associated with
higher IL-6 [51,55] and TNF-α [50]. Notably, adherence to a Mediterranean diet was
correlated with lower CRP [55].
Relationships between dietary GI/GL and inflammatory markers were inconsistent.
Inflammation was found to be positively associated with GI [3] and negatively associated
with high GL diets [11]. GI ranks carbohydrates according to their effect on blood glucose
levels [76]. GL takes both the quality and total amount of carbohydrates into consideration
and is a mathematical product of GI and the quantity of carbohydrates consumed [76].
An inverse association between GL, but not GI, and inflammatory markers [11] could
be a function of multiple factors. First, the GI and GL values were derived from a FFQ
measurement that consisted of broad food groupings [67], increasing the likelihood of
misclassification and an underestimation of an association [76]. Second, this particular FFQ
was shown to overestimate fruit intake [67], a systematic error that could lead to a biased
finding [77]. Third, a low GL diet could be low in carbohydrates but high in saturated
fat and protein [76], which are pro-inflammatory [78]. Compared to a high complex
carbohydrate/low fat dietary pattern, a conventional diet low in carbohydrates and high
in fat was associated with elevated inflammation during pregnancy [79]. Variations in
individual insulin response, mixed meals that influence the glycemic response, and food
processing techniques are other possible factors affecting GI/GL [76].
The association of DII with inflammatory markers was inconsistent across four studies [49,51,53,55]. Higher DII was associated with a higher concentration of CRP/hs-CRP
in two studies [52,56] but not replicated in the DII studies that showed a statistically
significant association between a pro-inflammatory diet and IL-6 [51,55]. One factor to
consider is that IL-6 is an inducer of hepatic CRP synthesis in hepatocytes [80,81]. Given
the mediating effects of IL-6 on the production of hs-CRP, the timing of inflammatory
marker measurement could influence the results [51]. In addition, DII was associated with
TNF-α only in the context of psychological stress. Among the DII studies, two containing
notable measurement issues showed a non-significant association between DII and inflammatory markers [49,53]. One cross-sectional study using NHANES data was limited by
its dietary measurement of a single 24-hour dietary recall [53] to represent usual dietary
intake, increasing the risk of exposure misclassification [77]. Another study included a DII
that was energy-adjusted to account for variation in the total energy consumption [49].
However, despite collecting multiple dietary assessments throughout pregnancy, blood
samples were collected only at enrollment. Given the changing nature of dietary intake
and inflammation during pregnancy, corresponding repeated measures are necessary to
reduce measurement error.
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Measurement of dietary intake can be challenging. Therefore, the majority of the
longitudinal studies used repeated measures of dietary assessments [3,49–52], enabling a
better estimation of habitual intake [77]. To improve dietary estimates, differing dietary
assessment tools can be used in combination [82]. For example, measurement error was
reduced in one investigation of adherence to the Mediterranean diet by using both a FFQ
and a 24-hour dietary recall [57]. Other factors that may have influenced associations
between dietary patterns and maternal inflammatory markers include confounding factors,
such as age, BMI [53,83], parity [11,83], and smoking status [83,84]. Nearly two-thirds
(n = 8) of the included observational studies adjusted for known confounders. Among
the observational studies with a full model adjustment, a significant association between
dietary pattern and inflammation was reported [3,50–52,60]. However, information regarding the use of anti-inflammatory medication (e.g., nonsteroidal anti-inflammatory
drugs) or the occurrence of acute infections (e.g., periodontitis, urinary tract infections) was
frequently left out [85]. Additionally, genetic and microbiome profiles that may influence
the inflammatory response to nutrients [85,86] were not considered.
4.2. Evidence from the Intervention Studies
Causal effects of the low GI diet, DASH diet, anti-atherogenic diet, and regular salmon
intake on inflammation during pregnancy were not evident in the examined RCTs. The
lack of blinding in many of the studies, although a challenge in dietary intervention
research [87], could lead to considerable expectation bias [88]. Unblinded participants
could change their behaviors, and unblinded outcome assessors could unintentionally
produce biased results, thereby inducing threats to internal validity [88].
The effect of dietary GI on CRP levels in pregnancy was not established [61]. Threeday food records were combined with 24-hour dietary recalls [61] to improve the accuracy
of dietary measurement. However, the intervention and control diets were similarly
healthy, which reduced variation in dietary exposure and the ability to detect differing
effects of the interventions [89]. In addition, this GI study may have been underpowered
given that inflammation was neither the primary nor secondary outcome [90]. Of note,
the specification of the type of carbohydrate was lacking in this study, decreasing the
interpretability of findings. A complex carbohydrate is mainly sourced from unprocessed
and whole, plant-based foods [91], whereas simple carbohydrates are often found in highly
processed foods [91]. Whole, plant-based foods are generally accepted as anti-inflammatory,
whereas ultra-processed foods are considered pro-inflammatory [92].
The DASH diet did not have an effect on hs-CRP concentrations in pregnant women.
However, the sample size of this RCT was small (n = 32), and groups reported similar
amounts of energy and protein intake and high amounts of vegetable and fruit intake
over the 4-week study period [54]. Additionally, associations between the omega-3 fatty
acid-enriched diet and plasma inflammatory markers were not established [58]. A study
that focused on the effects of routine salmon intake on cytokines using combined dietary
assessments (a FFQ and a seafood diary [66]) indicated a non-significant result. The
authors concluded that omega-3 intake may have been too low (<2 g/day) to reduce
inflammation [58].
The anti-atherogenic diet did not have an effect on the levels of hs-CRP and sCAMS
during pregnancy [59]. A reduced intake of cholesterol and saturated fat did not have
a lowering effect on inflammation, which is contrary to the results of the observational
study [3]. This discrepancy may be related to the methodological approach that included a
weekly weighted dietary intake on a pre-determined day throughout pregnancy [59]. The
predictability of this approach in the intervention study could have influenced participants’
dietary behaviors and compliance on the days of reporting their dietary intake. Furthermore, a type II error could have occurred, as a power calculation was not conducted for
the outcome of inflammation [59].
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4.3. Anti-inflammatory Markers and Inflammation Resolution
Few studies in this review addressed anti-inflammatory cytokines in relation to dietary patterns. Only IL-4 [49] and HGF [58] were examined. Specialized pro-resolving
mediators (SPMs), which are metabolites of omega-3 fatty acids responsible for resolving
inflammation [93], were not explored. Current understanding of the anti-inflammatory
properties of omega-3 fatty acids includes not only inhibition of pro-inflammatory signaling
molecules but also the involvement of pro-resolving mediators to accelerate inflammation
resolution [94,95]. Researchers have found that deficiencies in dietary omega-3 fatty acids
may result in insufficient precursors of pro-resolving mediators, leading to prolonged inflammation [94]. An anti-inflammatory approach [25] and pro-resolving mediators [95] are
emerging therapeutic targets for disease prevention in human research. To date, SPMs have
not been explored in studies focusing on maternal dietary patterns. Pro-resolving mediators
have only been explored in RCTs that focus on maternal dietary supplementation [96,97].
4.4. Strengths and Limitations
To the best of our knowledge, this is the first systematic review investigating dietary
patterns and their association with inflammatory markers during pregnancy. The included
studies were conducted in different pregnant populations across the globe, increasing the
generalizability of findings. However, the associations between dietary patterns and inflammatory markers during pregnancy must be interpreted with caution for three main reasons.
First, dietary assessment is a non-exact science and involves measurement problems. Second, variability in study design and rigor are evident, and third, types of dietary patterns
and a lack of exactness in their description contribute to a less cohesive finding. Circulating
cytokines (e.g., IL-6, IL-8, IL-1β, TNF-α) or CRP alone are non-specific inflammatory markers [90], and a consensus has not yet been reached for which markers are most pertinent or
reflective of phase or acuity of inflammation in pregnancy [81]. Additionally, the exclusion
of studies published in other languages limits the inclusion of findings reported by nonEnglish speaking populations. Finally, a meta-analysis could not be conducted because of
the methodological and statistical heterogeneity of the included studies.
4.5. Implications for Clinical Practice and Research
The findings of this review highlight the potential role of maternal dietary patterns to
shape the inflammatory response during pregnancy. Consuming certain dietary patterns
(e.g., high intake of saturated fats and low intake of fruits and vegetables) may contribute
to higher concentrations of inflammatory markers in pregnancy. Anti-inflammatory dietary
patterns correspond to healthy patterns of eating, which is consistent with adherence to
the current dietary recommendations. Future studies are needed to examine the changes
of anti-inflammatory markers and pro-resolving mediators in relation to maternal dietary
patterns to improve understanding of dietary effects in the context of pregnancy. In the
research design phase, researchers can consider the adjustment of multiple confounding
variables, such as psychosocial and lifestyle factors and the use of anti-inflammatory
medication. Additional longitudinal studies with robust methodology and large sample
sizes are needed to investigate the associations between dietary patterns and inflammatory
response among pregnant women.
5. Conclusions
Findings from the observational studies, although inconsistent, suggest that dietary
patterns may be associated with pro-inflammatory markers, such as CRP, IL-6, IL-8, TNF-α,
SAA, and GlycA, during pregnancy. Maternal dietary patterns characterized by high
intakes of animal protein and cholesterol, and/or low intakes of fiber were associated with
higher inflammatory status. However, all of the included intervention studies reported
no dietary effects on inflammation. The most commonly studied inflammatory marker in
pregnancy is CRP, but only 6 out of 13 studies showed any relationship of CRP with a dietary
pattern. Discrepancies in the findings among the assessed studies may be partly because
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of measurement errors and timing of data collection. These discrepancies are reflective
of the complexities and unknown ramifications of dietary effects on inflammation during
pregnancy. Future longitudinal studies investigating a broader range of inflammationrelated biomarkers throughout pregnancy, coupled with rigorous designs, are warranted.
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